Megan Blewett, PhD, is an associate on the healthcare team at Venrock, a venture capital firm in Palo Alto. She focuses on biotech and therapeutics investments. Prior to Venrock, Megan was a Hertz Fellow with Ben Cravatt at The Scripps Research Institute, where she earned a PhD in chemistry. Her PhD work explored the mechanism of action of the multiple sclerosis therapeutic Tecfidera and helped form the foundation of the biotech company Vividion.
Megan has a longstanding interest in epidemiology and while a PhD student founded the healthcare analytics company VoxHealth. She negotiated a licensing agreement with Google, and VoxHealth data is now a part of Google’s health knowledge graph.
Megan received an AB/AM in chemistry from Harvard University, where she spent nearly all four years working in the lab of chemistry Nobel Laureate EJ Corey and was awarded the Thomas T. Hoopes Prize for her senior thesis research.
In her spare time, Megan enjoys running. Megan is also a lock-picking enthusiast and has hosted several lock-picking events for Hertz Fellows.